The Community Focus Channel is supported with funding from Johnson & Johnson (Gold).
The Lymphoma Channel is supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
IWWM-12 2024 | Treating Bing-Neel syndrome: chemotherapy and BTK inhibitors
Monique Minnema, MD, PhD, University Medical Center Utrecht, Utrecht, Netherlands, discusses the treatment of Bing-Neel syndrome, highlighting that chemotherapy is often used. Prof. Minnema also speaks about the value of BTK inhibitors in treating this rare syndrome. This interview took place at the 12th International Workshop on Waldenström’s Macroglobulinemia (IWWM-12) in Prague, Czech Republic.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
